Sheng-Chieh Chou

7PUBLICATIONS
22CO-AUTHORS
Immunogenetics (incl. genetic immunology)Nanotoxicology, health and safetyGene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 05, 2026
Development of a novel hemophilia A mouse model to study emicizumab and factor VIII inhibitor risk.

Sheng-Chieh Chou, Yen-Ting Chang, Li-Fu Chen

|Feb 05, 2026
NXTAGE: a phase 1/2 study of NXT007 to assess safety, pharmacokinetics, and efficacy in hemophilia A without inhibitors.

Keiji Nogami, Chur-Woo You, Young-Shil Park

|Jul 12, 2025
Preclinical Evaluation of the Systemic Safety, Efficacy, and Biodistribution of a Recombinant AAV8 Vector Expressing FIX-TripleL in Hemophilia B Mice: Implications for Human Gene Therapy.

Sheng-Chieh Chou, Cheng-Po Huang, Ying-Hui Su

|May 19, 2025
Immune thrombotic thrombocytopenic purpura and diabetic ketoacidosis: a case report and literature review.

Geng-Hao Bai, Mei-Hwa Lin, Yu-Pei Chen

|Apr 11, 2025
Tissue factor, factor VIII and IX in microvesicle-induced thrombosis and tumor growth of pancreatic cancer.

Sheng-Chieh Chou, Shu-Lun Chang, Cheng-Yeh Yu

|Oct 11, 2023
Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan.

Ming-Ching Shen, Sheng-Chieh Chou, Shyh-Shin Chiou

Pageof 2

Frequent Collaborators

2 joint publications

Ming-Ching Shen

2 joint publications

Shu-Wha Lin

1 joint publications

Yen-Bo Liu

1 joint publications

Lu-Ting Kuo